Fingerprint
Dive into the research topics of 'Phase i study of a modified regimen of 90yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed cd20+ non-hodgkin lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically